0001439222-24-000085.txt : 20240617
0001439222-24-000085.hdr.sgml : 20240617
20240617172251
ACCESSION NUMBER: 0001439222-24-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240617
DATE AS OF CHANGE: 20240617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ballal Rahul D.
CENTRAL INDEX KEY: 0001805097
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 241049357
MAIL ADDRESS:
STREET 1: 116 HUNTINGTON AVENUE
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20080703
4
1
wk-form4_1718659363.xml
FORM 4
X0508
4
2024-06-13
0
0001439222
AGIOS PHARMACEUTICALS, INC.
AGIO
0001805097
Ballal Rahul D.
C/O AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
0
Common stock
2024-06-13
4
M
0
3388
0
A
5690
D
Restricted stock units
2024-06-13
4
M
0
3388
0
D
Common stock
3388
0
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
/s/ William Cook, as attorney-in-fact for Rahul Ballal
2024-06-17